Guanidinoethyldisulfide

Drug Profile

Guanidinoethyldisulfide

Alternative Names: GED; Gingivex; Guanidinoethyldisulfide bicarbonate; Inducible nitric oxide synthase inhibitor - Inotek Pharmaceuticals; iNOS inhibitor - Inotek Pharmaceuticals

Latest Information Update: 08 Aug 2007

Price : $50

At a glance

  • Originator Inotek Pharmaceuticals
  • Class Guanidines; Small molecules
  • Mechanism of Action Nitric oxide synthase type II inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Gingivitis; Stomatitis; Uveitis

Most Recent Events

  • 08 Aug 2007 Discontinued - Phase-II for Gingivitis in USA (Topical)
  • 08 Aug 2007 Discontinued - Phase-II for Stomatitis in USA (Topical)
  • 08 Aug 2007 Discontinued - Preclinical for Uveitis in USA (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top